FDA Pharmacovigilance Status Quo: Do you know? The Food and Drug Administration’s (FDA’s) Adverse Event Reporting System (FAERS) contains 25 million adverse event reports in its database. The Agency processes more than 2 million ADRs
Read More
The Evolving Pharma Landscape: Innovation Demands AgilityThe pharmaceutical industry is a dynamic ecosystem where innovation never sleeps. From advancements in manufacturing technologies to shifts in formulation strategies, post-approval changes are inevitable. Yet, every modification—whether to
Read More
Introduction The landscape of clinical trials is undergoing a seismic shift. No longer confined to rigid protocols and centralized labs, modern clinical research is embracing patient-centric innovation to deliver faster, safer, and more inclusive outcomes.
Read More
As healthcare advances, new treatment modalities, personalized medicines, and innovative technologies are reshaping the landscape.
Read More
Welcome to the latest edition of our Pharma News and Regulatory News Updates, where we bring you the most significant developments and breakthroughs in the pharmaceutical industry and the latest updates from regulatory agencies worldwide.
Read More
Pharmacovigilance guidelines serve as essential frameworks and standards that govern the practice of pharmacovigilance globally. These guidelines provide guidance and recommendations for various stakeholders involved in drug safety monitoring, including regulatory authorities, pharmaceutical companies, healthcare
Read More